Furey Doolan & Abell Llp Chevy Chase, MD - 20815

Furey Doolan & Abell Llp is categorized under Law Firms and Law Offices in Chevy Chase, MD and active since 1973.

Furey Doolan & Abell Llp was established in 1973, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Law Firms and Law Offices business, which does work in the B2B market, and is classified as a Law Firms and Law Offices, under code number 5411100 by the NAICS.

If you are seeking more information, feel free to contact Elsie Reid, Partner at the company’s single location by writing to 8401 Connecticut Avenue # 1100, Chevy Chase, Maryland MD 20815 or by phoning (301) 652-6880. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Furey Doolan & Abell Llp
Contact Person: Elsie Reid, Partner
Address: 8401 Connecticut Avenue # 1100, Chevy Chase, Maryland 20815
Phone Number: (301) 652-6880
Website Address: fdalaw.com
Annual Revenue (USD): $2.500.000 to $4.999.999
Founded: 1973
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Law Firms and Law Offices
SIC Code: 8111
NAICS Code: 5411100
Share This Business:

Furey Doolan & Abell Llp was started in 1973 to provide professional Law Firms and Law Offices under the SIC code 8111 and NAICS code 5411100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.

Feel free to contact Elsie Reid, Partner for inquiries that concern Furey Doolan & Abell Llp by calling the company number (301) 652-6880, as your correspondence is most welcome. Additionally, the physical location of the single location of Furey Doolan & Abell Llp can be found at the coordinates 38.994172,-77.07709 as well as the street address 8401 Connecticut Avenue # 1100 in Chevy Chase, Maryland 20815.

For its online presence, you may visit Furey Doolan & Abell Llp’s website at fdalaw.com and engage with its social media outlets through on Twitter and on Facebook.